BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23463663)

  • 1. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.
    Mosquera JM; Sboner A; Zhang L; Kitabayashi N; Chen CL; Sung YS; Wexler LH; LaQuaglia MP; Edelman M; Sreekantaiah C; Rubin MA; Antonescu CR
    Genes Chromosomes Cancer; 2013 Jun; 52(6):538-50. PubMed ID: 23463663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with
    Colletti M; Galardi A; Miele E; Di Paolo V; Russo I; De Stefanis C; De Vito R; Rinelli M; Ciolfi A; De Angelis B; Zin A; Guffanti A; Digilio MC; Novelli A; Alaggio R; Milano GM; Di Giannatale A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34067464
    [No Abstract]   [Full Text] [Related]  

  • 3. A rare case of congenital spindle cell rhabdomyosarcoma with TEAD1-NCOA2 fusion: A subset of spindle cell rhabdomyosarcoma with indolent behavior.
    Tan GZL; Saminathan SN; Chang KTE; Odoño EG; Kuick CH; Chen H; Lee VKM
    Pathol Int; 2020 Apr; 70(4):234-236. PubMed ID: 31999033
    [No Abstract]   [Full Text] [Related]  

  • 4. A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.
    Alaggio R; Zhang L; Sung YS; Huang SC; Chen CL; Bisogno G; Zin A; Agaram NP; LaQuaglia MP; Wexler LH; Antonescu CR
    Am J Surg Pathol; 2016 Feb; 40(2):224-35. PubMed ID: 26501226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.
    Sumegi J; Streblow R; Frayer RW; Dal Cin P; Rosenberg A; Meloni-Ehrig A; Bridge JA
    Genes Chromosomes Cancer; 2010 Mar; 49(3):224-36. PubMed ID: 19953635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
    Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
    Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.
    Agaram NP; Zhang L; Sung YS; Cavalcanti MS; Torrence D; Wexler L; Francis G; Sommerville S; Swanson D; Dickson BC; Suurmeijer AJH; Williamson R; Antonescu CR
    Am J Surg Pathol; 2019 May; 43(5):695-702. PubMed ID: 30720533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.
    Jin Y; Möller E; Nord KH; Mandahl N; Von Steyern FV; Domanski HA; Mariño-Enríquez A; Magnusson L; Nilsson J; Sciot R; Fletcher CD; Debiec-Rychter M; Mertens F
    Genes Chromosomes Cancer; 2012 May; 51(5):510-20. PubMed ID: 22337624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
    Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
    Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells.
    Yoshida H; Miyachi M; Sakamoto K; Ouchi K; Yagyu S; Kikuchi K; Kuwahara Y; Tsuchiya K; Imamura T; Iehara T; Kakazu N; Hojo H; Hosoi H
    Oncogene; 2014 Dec; 33(49):5601-8. PubMed ID: 24213582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
    Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817
    [No Abstract]   [Full Text] [Related]  

  • 12. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
    Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
    Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft tissue angiofibroma: Clinicopathologic, immunohistochemical and molecular analysis of 14 cases.
    Bekers EM; Groenen PJTA; Verdijk MAJ; Raaijmakers-van Geloof WL; Roepman P; Vink R; Gilhuijs NDB; van Gorp JM; Bovée JVMG; Creytens DH; Flanagan AM; Suurmeijer AJH; Mentzel T; Arbajian E; Flucke U
    Genes Chromosomes Cancer; 2017 Oct; 56(10):750-757. PubMed ID: 28639284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens.
    Montoya-Cerrillo DM; Diaz-Perez JA; Velez-Torres JM; Montgomery EA; Rosenberg AE
    Genes Chromosomes Cancer; 2021 Oct; 60(10):687-694. PubMed ID: 34184341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
    Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
    Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraosseous Spindle Cell Rhabdomyosarcoma with
    Smith BF; Doung YC; Beckett B; Corless CL; Davis LE; Davis JL
    Cancer Invest; 2023 Sep; 41(8):704-712. PubMed ID: 37668330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
    Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
    Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
    Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of NCOA2 fluorescence in situ hybridization and Stat6 immunohistochemistry staining for soft tissue angiofibroma and morphologically similar fibrovascular tumors.
    Sugita S; Aoyama T; Kondo K; Keira Y; Ogino J; Nakanishi K; Kaya M; Emori M; Tsukahara T; Nakajima H; Takagi M; Hasegawa T
    Hum Pathol; 2014 Aug; 45(8):1588-96. PubMed ID: 24856853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
    Rekhi B; Singhvi T
    APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.